Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77K Buy
+172
New +$1.74K ﹤0.01% 9474
2026
Q1
Sell
-90
Closed -$1.33K 10648
2025
Q4
$1.33K Buy
+90
New +$1.18K ﹤0.01% 9627
2025
Q2
Sell
-326
Closed -$2.65K 10366
2025
Q1
$2.65K Sell
326
-2,273
-87% -$17.8K ﹤0.01% 9296
2024
Q4
$20K Buy
2,599
+1,363
+110% +$12K ﹤0.01% 7871
2024
Q3
$10.7K Sell
1,236
-2,917
-70% -$26.1K ﹤0.01% 7715
2024
Q2
$38.7K Buy
4,153
+2,993
+258% +$28.1K ﹤0.01% 6888
2024
Q1
$10.3K Buy
+1,160
New +$10K ﹤0.01% 7235
2023
Q4
Sell
-134
Closed -$1.26K 9430
2023
Q3
$1.26K Sell
134
-2,315
-95% -$22.5K ﹤0.01% 8019
2023
Q2
$23.5K Buy
+2,449
New +$26.1K ﹤0.01% 6805
2022
Q4
Sell
-826
Closed -$11K 10802
2022
Q3
$11K Sell
826
-104
-11% -$1.39K ﹤0.01% 8283
2022
Q2
$12K Buy
930
+75
+9% +$904 ﹤0.01% 7647
2022
Q1
$9K Buy
855
+208
+32% +$2.28K ﹤0.01% 8539
2021
Q4
$7K Buy
647
+430
+198% +$4.74K ﹤0.01% 9141
2021
Q3
$3K Sell
217
-716
-77% -$7.29K ﹤0.01% 8799
2021
Q2
$10K Buy
933
+499
+115% +$5.29K ﹤0.01% 8034
2021
Q1
$5K Sell
434
-876
-67% -$11.1K ﹤0.01% 8307
2020
Q4
$16K Buy
1,310
+559
+74% +$7.74K ﹤0.01% 7105
2020
Q3
$12K Buy
+751
New +$12.7K ﹤0.01% 6695
2020
Q1
Sell
-1,155
Closed -$11K 8044
2019
Q4
$11K Buy
+1,155
New +$10.9K ﹤0.01% 7230
2019
Q2
Sell
-1,370
Closed -$15K 7920
2019
Q1
$15K Buy
+1,370
New +$20.5K ﹤0.01% 6534
2018
Q4
Sell
-2,908
Closed -$15K 8086
2018
Q3
$15K Buy
2,908
+889
+44% +$4.89K ﹤0.01% 6959
2018
Q2
$13K Buy
2,019
+1,726
+589% +$12.5K ﹤0.01% 6981
2018
Q1
$3K Sell
293
-2,273
-89% -$13.1K ﹤0.01% 7414
2017
Q4
$12K Sell
2,566
-5
-0.2% -$24 ﹤0.01% 6903
2017
Q3
$13K Buy
+2,571
New +$14.9K ﹤0.01% 6730
2016
Q2
Sell
-492
Closed -$4K 7778
2016
Q1
$4K Buy
+492
New +$3.88K ﹤0.01% 7078
2015
Q3
Sell
-2,147
Closed -$15K 8454
2015
Q2
$15K Buy
2,147
+1,831
+579% +$13.2K ﹤0.01% 7129
2015
Q1
$2K Buy
+316
New +$2.01K ﹤0.01% 8437

Other funds holding DXR

UBS Group's DXR Position: Q2 2026 in Review

UBS Group opened a new position in Daxor (DXR) in Q2 2026: 172 shares worth $1.77K. The stake represents ﹤0.01% of the portfolio and ranks #9474 among its holdings. This is a return to the name: UBS Group previously reported a position in DXR as recently as Q4 2025.

UBS Group first reported a position in DXR in Q1 2015 and has held it in 28 quarters since. The position peaked at $38.7K in Q2 2024. 14 funds tracked by Wall St. Rank hold DXR as of Q2 2026.

  • UBS Group held 172 shares of Daxor worth $1.77K as of Q2 2026.
  • Daxor was a new UBS Group position in Q2 2026.
  • Daxor made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9474 holding.
  • UBS Group first reported a position in Daxor in Q1 2015 and has held it in 28 quarters since.
  • UBS Group's Daxor position peaked at $38.7K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Daxor as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.